XP6-19128-64657
3 vaccinations
0 coded responses
4 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 981 / WA
- Registered
- 2021-09-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Dose 2 — Pfizer-BioNTech
-
2021-09-24
Dose 3 — Pfizer-BioNTechCo-administered: yes
-
2021-09-26
Registered in v-safe
-
2021-09-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-09-29
- 2021-10-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | No |
| 2 | 2021-01-28 | Pfizer-BioNTech | No |
| 3 | 2021-09-24 | Pfizer-BioNTech | Yes |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.